Showing results (1-10 of 132) with videos related to
Sort By:
Pageof 14
Melanoma Research|February 2, 2023
Pembrolizumab-induced plaque psoriasis successfully treated with risankizumab in a patient with stage IV cutaneous melanomaLuigi Gargiulo, Luciano Ibba, Mario Valenti, et al.Journal of Crohn'S & Colitis|May 13, 2022
What Can IBD Specialists Learn from IL-23 Trials in Dermatology?Mario Valenti, Alessandra Narcisi, Giulia Pavia, et al.Dermatology Reports|February 19, 2025
Intra-class switch among interleukin-17 inhibitors for the treatment of plaque psoriasis: a single-center experienceGioele Ghezzi, Luciano Ibba, Luigi Gargiulo, et al.Journal of Personalized Medicine|February 23, 2024
Effectiveness and Safety of Biological Therapies in Very Severe Plaque Psoriasis: A Real-Life Retrospective StudyGiovanni Fiorillo, Luciano Ibba, Luigi Gargiulo, et al.Dermatology Reports|April 16, 2024
A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeksLuciano Ibba, Luigi Gargiulo, Giulia Pavia, et al.Dermatology and Therapy|January 8, 2023
Real-Life Effectiveness and Safety of Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A Single-Center 16-Week StudyLuigi Gargiulo, Luciano Ibba, Andrea Cortese, et al.The Journal of Dermatological Treatment|February 22, 2023
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case seriesLuigi Gargiulo, Luciano Ibba, Giulia Pavia, et al.Clinical, Cosmetic and Investigational Dermatology|March 18, 2024
Practical Use of Upadacitinib in Patients with Severe Atopic Dermatitis in a Real-World Setting: A Systematic ReviewLuciano Ibba, Luigi Gargiulo, Carlo Alberto Vignoli, et al.Dermatologic Therapy|November 25, 2021
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative studyAlessandra Narcisi, Mario Valenti, Andrea Cortese, et al.The Journal of Dermatological Treatment|March 31, 2023
Long-term management of pediatric psoriasis with ixekizumab: a case reportDiego Orsini, Luciano Ibba, Alessandra Narcisi, et al.Pageof 14